Philip Morris Is Still Pricey And Could Retrace Further

Philip Morris (PM) delivered strong Q2 2024 results, driven by record revenues, robust smoke-free product growth, and expanding operating margins. Despite this operational momentum, the stock's current valuation is deemed stretched compared to peers, leading to a neutral outlook with an anticipated retracement to $147 for a more compelling entry point and a 4% dividend yield. While the company's transition to smoke-free products is promising, regulatory, health, and market risks persist, suggesting future returns may not mirror past performance.

Analysis

Philip Morris (PM) has demonstrated strong operational performance, reporting record revenues and expanding operating margins in its Q2 2024 results, driven primarily by robust growth in its smoke-free product segment. Despite this positive fundamental momentum and a significant stock price breakout, the current valuation is viewed as stretched relative to industry peers Altria (MO) and British American Tobacco (BTI), diminishing its risk/reward attractiveness. The analysis suggests a neutral stance, anticipating a potential price retracement to approximately $147, a level that would offer a more compelling entry point with an associated 4% dividend yield. While the strategic pivot to smoke-free products is promising for long-term growth, persistent regulatory, health, and market risks temper the outlook, implying that future returns may not replicate past performance.

Key Decisions for Investors

• Investors may consider waiting for a pullback toward the $147 price level before initiating or adding to positions, as this is identified as a more attractive entry point with a better risk/reward profile.
• Current holders of PM should weigh the stock's stretched valuation against its operational strength and consider trimming positions to lock in gains, given the potential for a near-term price retracement.
• A comparative valuation analysis against peers MO and BTI is warranted, as the current market suggests these competitors might offer a more compelling value proposition.
• Monitor regulatory developments and health-related news closely, as these remain significant risk factors that could impact the long-term success of PM's transition to smoke-free products and its overall valuation.